Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients
NCT ID: NCT02297763
Last Updated: 2014-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
194 participants
INTERVENTIONAL
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
quetiapine
quetiapine 12.5mg (bwt \<50kg ) or 25mg (bwt\>= 50kg) study medicine is pulverized to power and melted in 10cc tepid water. The study medicine(quetiapine) will be provided as liquid form.
quetiapine
patient body weight \<50kg : quetiapine 12.5mg patient body weight \>=50kg : quetiapine 25mg
quetiapine 12.5mg (bwt \<50kg ) or 25mg (bwt\>= 50kg) study medicine is pulverized to power and melted in 10cc tepid water. The study medicine(quetiapine) will be provided as liquid form.
The study medicine(quetiapine) was provided as liquid form (medicine was pulverized and melted in 10cc water).
placebo
The placebo is made of 100mg of corn starch which is melted in 10cc water.
placebo
The placebo is made of 100mg of corn starch which is melted in 10cc water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
quetiapine
patient body weight \<50kg : quetiapine 12.5mg patient body weight \>=50kg : quetiapine 25mg
quetiapine 12.5mg (bwt \<50kg ) or 25mg (bwt\>= 50kg) study medicine is pulverized to power and melted in 10cc tepid water. The study medicine(quetiapine) will be provided as liquid form.
The study medicine(quetiapine) was provided as liquid form (medicine was pulverized and melted in 10cc water).
placebo
The placebo is made of 100mg of corn starch which is melted in 10cc water.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active delirium
* Received other anti-psychotic drug before attend the study
* severe bradycardia
* alcohol intoxication
* No written consent from the legal representatives
* Being ill with renal or hepatic failure
19 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YJLSM2014
Identifier Type: -
Identifier Source: org_study_id